Alkaline ribonuclease inhibitor in human thyroid

Area of Science:

• Biochemistry
• Endocrinology
• Molecular Biology

Background:

• Thyroid function is regulated by complex molecular mechanisms.
• Ribonucleases (RNases) play a role in RNA metabolism within the thyroid.
• Alkaline ribonuclease inhibitor (ARI) has been identified in rat thyroids.

Purpose of the Study:

• To investigate the levels of ARI in human thyroids.
• To determine if ARI levels correlate with thyroid status, specifically hyperthyroidism.
• To characterize the properties of human thyroid ARI.

Main Methods:

• Quantification of ARI activity in thyroid tissue from hyperthyroid patients and normal individuals.
• Comparison of ARI levels with RNA concentration in thyroid tissue.
• Characterization of ARI properties including heat lability, sensitivity to sulfhydryl blocking agents, and molecular weight.
• Analysis of ARI in a solitary toxic nodule and surrounding suppressed tissue.

Main Results:

• Thyroids from hyperthyroid patients contain significantly higher amounts of ARI compared to normal thyroids.
• The increase in ARI concentration parallels the increase in RNA concentration in hyperthyroid thyroids.
• Human thyroid ARI is heat labile, inactivated by sulfhydryl blocking agents, and has a molecular weight of approximately 50,000 daltons.
• ARI inhibits both bovine pancreatic RNase and human thyroid RNase.
• Findings were consistent in single-patient analyses, reducing the likelihood of medication effects.

Conclusions:

• Hyperthyroidism is associated with increased levels of alkaline ribonuclease inhibitor (ARI) in the thyroid.
• ARI may play a regulatory role in thyroid RNA metabolism, potentially influencing RNA concentration.
• Further research is warranted to elucidate the precise function and regulatory role of ARI in thyroid physiology and pathology.